Pharmacokinetics, tolerability and bacteriological response of 600, 900 and 1200 mg rifampicin daily in patients with pulmonary TB

Aarnoutse, R. E.; Kibiki, G. S.; Reither, K; Semvua, H. H.; Haraka, F; Mtabho, C. M.; Mpagama, S. G.; van den Boogaard, J; Sumari-de Boer, I. M.; Magis-Escurra, C; Wattenberg, M; Logger, J. G. M.; te Brake, L. H. M.; Hoelscher, M; Gillespie, S. H.; Colbers, A; Phillips, P. P. J.; Plemper van Balen, G; Boeree, M. J.

期刊名称Antimicrobial Agents and Chemotherapy
作者Aarnoutse, R. E.; Kibiki, G. S.; Reither, K; Semvua, H. H.; Haraka, F; Mtabho, C. M.; Mpagama, S. G.; van den Boogaard, J; Sumari-de Boer, I. M.; Magis-Escurra, C; Wattenberg, M; Logger, J. G. M.; te Brake, L. H. M.; Hoelscher, M; Gillespie, S. H.; Colbers, A; Phillips, P. P. J.; Plemper van Balen, G; Boeree, M. J.
印刷ISSN0066-4804
电子ISSN1098-6596
文件大小1206.01KB
发表时间2017-08-21
DOI10.1128/AAC.01054-17

发现好书期刊，享受阅读乐趣

Pharmacokinetics, tolerability and bacteriological response of 600, 900 and 1200 mg rifampicin daily in patients with pulmonary TB